Collects data and blood samples from people with interstitial lung disease
Collects data and blood samples from people with lung disease and a comparison group.
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- Status
- Recruiting
- People taking part
- 4,000 people, planned
- Started
- Sept 2005
- Expected to end
- Dec 2030
- Type of study
- Observational
- Record updated
- 9 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have interstitial lung disease. It also collects data and blood from a control group for comparison.
- Age
- 18 years or older
- Sex
- Men and women
- Disease stage
- Interstitial lung disease (for example idiopathic pulmonary fibrosis, sarcoidosis, connective tissue disorder)
Main reasons for not taking part
- People who do not have interstitial lung disease
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Interstitial lung disease
Who cannot take part
- Does not have Interstitial lung disease
Where in United States
- University of ChicagoChicago, United StatesContact: Mary E Strek, MDTaking people
About the trial
What the trial wants to find out
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- Plain-language title
- Collects data and blood samples from people with interstitial lung diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 June 2026